Quinapril hydrochloride

This classification denotes a tetrahydroisoquinoline, angiotensin-converting enzyme inhibitor, and antihypertensive agent with the molecular formula C25H30N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33067B3N2M, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3s-(2(r*(r*)),3r*)) but more generally known as quinapril hydrochloride, which bears US NIH Compound Identifier 54891. European Medicines Agency schedules Quinapril hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04164MIG. Most nations, for tariff and trade purposes, schedule quinapril hydrochloride under HS 29334990 and SITC 51575. As of Q4 2014, QUINAPRIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Quinapril hydrochloride bears US NLM identifiers UMLS ID C0770920 and NCI Concept Code C29398. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N2CC3CCCCC3C[C@H]2C(=O)O.CL.